Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases
Ageing Research Reviews · 2025-08 · 110 · 102802
DOI: 10.1016/j.arr.2025.102802 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025-08. Verfasst von Giovanni Brandi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: giovanni.brandi@unibo.it.it. Hauptthemen laut MEDLINE: Hydrogen, Aging. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 377 Literaturangaben. Gefördert von: Università di Bologna, University of Bologna.
Abstract (Originalsprache)
Aging represents the main risk factor for the development of several diseases, including cardiovascular and metabolic conditions, neurodegenerative disorders and cancer. As the number of elderly people is increasing worldwide, different strategies to counteract age-related diseases have been investigated. Recently, the use of molecular hydrogen (H2) as a preventive and therapeutic approach has been proposed due to its antioxidant and anti-inflammatory properties, its ability to regulate cell senescence and death, and to restore intestinal eubiosis. Although the studies investigating the role of H2 in slowing-down aging and age-related diseases are still limited, current findings support the idea that its administration may be able to affect different hallmarks of these processes. The "democratic" characteristics of H2 rely on its potential widespread use due to its pleiotropic activity, the lack of toxicities and low costs. In this review we provide a comprehensive state of the art on current knowledge on the molecular and clinical features of aging and age-related diseases. Current therapeutic approaches to slow down these processes will be also discussed, with a main focus on the potential use of H2 as an innovative preventive and therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: giovanni.brandi@unibo.it.it.
- Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
- Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Blue Hydrogen Science, Belluno, Italy.
Förderung
- Università di Bologna
- University of Bologna
Zitieren
APA
Brandi, G., Delbaldo, C., Deserti, M., Relli, V., Rimedio, S., Palloni, A., Deiana, C., Saccoccio, G., Ingenito, R., & Tavolari, S. (2025). Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases. Ageing Research Reviews, 110, 102802. https://doi.org/10.1016/j.arr.2025.102802
Vancouver
Brandi G, Delbaldo C, Deserti M, Relli V, Rimedio S, Palloni A, et al. Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases. Ageing Research Reviews. 2025;110:102802. doi:10.1016/j.arr.2025.102802
BibTeX
@article{Brandi2025,
author = {Brandi, Giovanni and Delbaldo, Chiara and Deserti, Marzia and Relli, Valeria and Rimedio, Simone and Palloni, Andrea and Deiana, Chiara and Saccoccio, Gioconda and Ingenito, Raffaele and Tavolari, Simona},
title = {Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases},
journal = {Ageing Research Reviews},
year = {2025},
volume = {110},
pages = {102802},
doi = {10.1016/j.arr.2025.102802}
}
EUVIMED